ORGANIC
LETTERS
2002
Vol. 4, No. 5
819-822
Synthesis of (−)-Ilimaquinone via a
Radical Decarboxylation and Quinone
Addition Reaction
Taotao Ling, Erwan Poupon, Erik J. Rueden, and Emmanuel A. Theodorakis*
Department of Chemistry and Biochemistry, UniVersity of California,
San Diego, 9500 Gilman DriVe, La Jolla, California 92093-0358
Received January 1, 2002
ABSTRACT
A stereoselective synthesis of (−)-ilimaquinone (4) is presented. The synthetic strategy is based on a novel radical decarboxylation and
quinone addition methodology that produces quinone 7 from reaction of thiohydroxamic acid derivative 8 with benzoquinone (9). Final
functionalization of 7 to ilimaquinone (4) is achieved by exploring the electronic effects of the residual thiopyridyl group.
Marine organisms represent a rich source of natural products
that often possess novel chemical structures and interesting
biological and pharmacological properties.1 Among these
products is included a family of quinone sesquiterpenes,
selected members of which are avarol (1),2 avarone (2),2
nakijiquinone A (3),3 ilimaquinone (4),4 smenospongine (5),5
and smenospongidine (6)5 (Figure 1).
All members of this family are distinguished by a common
chemical architecture in which the C9 position of a trans-
decalin ring is attached to a variably hydroxylated (or
heteroatom substituted) quinone or hydroquinone unit.
Interestingly, this nearly identical structural motif translates
to a variety of exciting biological properties often unique to
each family member. For example, avarol (1) and avarone
(2) have been shown to exhibit anti-HIV properties,6 while
nakijiquinone A (3) was found to inhibit selectively the Her-
2/Neu protooncogene.3,7 On the other hand, ilimaquinone (4)
was found to exhibit anti-HIV, antimitotic, and antiinflam-
matory activities,8 in addition to promoting a reversible
vesiculation of the Golgi apparatus and interfering with
intracellular protein trafficking.9
(1) Biomedical Importance of Marine Organisms; Fautin, D. G., Ed.;
Memoirs Calif. Acad. Sci 13. 1988, 1-158. Capon, R. J. Eur. J. Org. Chem.
2001, 633-645.
(6) Mu¨ller, W. E. G.; Sladic, D.; Zahn, R. K.; Ba¨ssler, K.-H.; Dogovic,
N.; Gerner, H.; Gasic, M. J.; Schro¨der, H. C. Cancer Res. 1987, 47, 6565-
6571. Loya, S.; Hizi, A. FEBS 1990, 269, 131-134. Schro¨der, H. C.; Begin,
M. E.; Klo¨cking, R.; Matthes, E.; Sarma, A. S.; Gasic, M.; Mu¨ller, W. E.
G. Virus Res. 1991, 21, 213-223. De Clercq, E. Med. Res. ReV. 2000, 5,
323-349.
(7) For an interesting account on the synthesis and biological investigation
of this natural product, see: Stahl, P.; Waldmann, H. Angew. Chem., Int.
Ed. 1999, 38, 3710-3713. Stahl, P.; Kissau, L.; Mazitschek, R.; Huwe,
A.; Furet, P.; Giannis, A.; Waldmann, H. J. Am. Chem. Soc. 2001, 123,
11586-11593.
(2) Minale, L.; Ricio, R.; Sodano, G. Tetrahedron Lett. 1974, 38, 3401-
3404. DeRosa, S.; Minale, L.; Riccio, R.; Sodano, G J. Chem. Soc., Perkin
Trans. I 1976, 1408-1414. Puliti, R.; deRosa, S.; Mattia, C. A. Acta
Crystallogr. Sect. C 1994, C50, 830-833. Stewart, M.; Fell, P. M.; Blunt,
J. W.; Munro, M. H. G. Aust. J. Chem. 1997, 50, 341-347.
(3) Shigemori, H.; Madono, T.; Sasaki, T.; Mikami, Y.; Kobayashi, J.
Tetrahedron 1994, 50, 8347-8354. Kobayashi, J.; Madono, T.; Shigemori,
H. Tetrahedron 1995, 51, 10867-10874.
(4) Luibrand, R. T.; Erdman, T. R.; Vollmer, J. J.; Scheuer, P. J.; Finer,
J.; Clardy, J. C. Tetrahedron 1979, 35, 609-612. Capon, R. J.; MacLeod,
J. K. J. Org. Chem. 1987, 52, 5059-5060. Carte´, B.; Rose, C. B.; Faulkner,
D. J. J. Org. Chem. 1985, 50, 2785-2787.
(5) Kondracki, M.-L.; Guyot, M. Tetrahedron Lett. 1987, 28, 5815-
5818. Kondracki, M.-L.; Guyot, M. Tetrahedron 1989, 45, 1995-2004.
(8) Loya, S.; Tal, R.; Kashman, Y.; Hizi, A. Antimicrob. Agents
Chemother. 1990, 1990, 2009-2012. Loya, S.; Hizi, A. J. Biol. Chem. 1993,
268, 9323-9328. Rangel, H. R.; Dagger, F.; Compagnone, R. S. Cell Biol.
Intern. 1997, 21, 337-339.
10.1021/ol025501z CCC: $22.00 © 2002 American Chemical Society
Published on Web 02/12/2002